The Regulatory Effects of Citrus Peel Powder on Liver Metabolites and Gut Flora in Mice with Non-Alcoholic Fatty Liver Disease (NAFLD)

被引:47
作者
Hu, Meiyi [1 ,2 ,3 ]
Zhang, Li [2 ,3 ]
Ruan, Zheng [1 ,2 ,3 ]
Han, Peiheng [2 ,3 ]
Yu, Yujuan [2 ,3 ]
机构
[1] Beijing Technol & Business Univ BTBU, Beijing Adv Innovat Ctr Food Nutr & Human Hlth, Beijing 100048, Peoples R China
[2] Nanchang Univ, Inst Nutr, State Key Lab Food Sci & Technol, Nanchang 330047, Jiangxi, Peoples R China
[3] Nanchang Univ, Sch Food Sci, Nanchang 330047, Jiangxi, Peoples R China
关键词
citrus peel; liver metabolites; gut flora; non-alcoholic fatty liver disease; pomelo; orange; FECAL MICROBIOTA; OBESITY; PECTINS;
D O I
10.3390/foods10123022
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Gannan navel orange and Jinggang pomelo, belonging to the genus Citrus, are good sources of phenolic compounds, which are mainly concentrated in the peel. These phenolic compounds are considered promising in the prevention and treatment of non-alcoholic fatty liver disease (NAFLD). In order to maximize nutrients retention and bioactivity in the peel, pomelo peel and orange peel were processed using freeze-drying technology and mixed in the ratio (pomelo peel powder 50% and orange peel powder 50%) to make citrus peel powder (CPP). The purpose of this study was to explore new strategies and mechanisms associated with the consumption of CPP to alleviate nonalcoholic fatty liver injury, lipid metabolism disorders, and gut microbiota dysbiosis in obese mice induced by high-fat diet (HFD). The results showed that after 12 weeks of CPP administration, CPP supplementation had a strong inhibitory effect on HFD-induced weight gain, hepatic fat accumulation, dyslipidemia, and the release of pro-inflammatory cytokines. In particular, CPP modulates the composition of the intestinal flora, such as increasing the relative abundance of phylum Firmicutes, genus Faecalibaculum, genus Lactobacillus, genus Dubosiella, and genus Lachnospiraceae_NK4A136_ group and decreasing the relative abundance of phylum Bacteroidota, genus Helicobacter, and genus Bacteroides. These results suggest that CPP has a preventive effect on NAFLD, which can be related to the regulation of intestinal flora.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] Gut microbia dysbiosis in non-alcoholic fatty liver disease
    Guss, Debra A.
    Mohanty, Smruti R.
    TRANSLATIONAL CANCER RESEARCH, 2016, 5 : S152 - S155
  • [42] Lean non-alcoholic fatty liver disease (Lean-NAFLD): a major cause of cryptogenic liver disease
    Vos, Bertrand
    Moreno, Christophe
    Nagy, Nathalie
    Fery, Francoise
    Cnop, Miriam
    Vereerstraeten, Pierre
    Deviere, Jacques
    Adler, Michael
    ACTA GASTRO-ENTEROLOGICA BELGICA, 2011, 74 (03): : 389 - 394
  • [43] Hepatoprotective effects of Cassiae Semen on mice with non-alcoholic fatty liver disease based on gut microbiota
    Luo, Hanyan
    Wu, Hongwei
    Wang, Lixia
    Xiao, Shuiming
    Lu, Yaqi
    Liu, Cong
    Yu, Xiankuo
    Zhang, Xiao
    Wang, Zhuju
    Tang, Liying
    COMMUNICATIONS BIOLOGY, 2021, 4 (01)
  • [44] Prebiotics targeting gut-liver axis to treat non-alcoholic fatty liver disease
    Castelnuovo, Gabriele
    Perez-Diaz-Del-Campo, Nuria
    Guariglia, Marta
    Poggiolini, Irene
    Armandi, Angelo
    Rosso, Chiara
    Caviglia, Gian P.
    Bugianesi, Elisabetta
    MINERVA GASTROENTEROLOGY, 2024, 70 (04): : 446 - 453
  • [45] Non-alcoholic Fatty Liver Disease (NAFLD) and non-alcoholic Steatohepatitis (NASH): Pathophysiology and Nutritional Aspects
    Schattenberg, Joern M.
    ERNAHRUNGS UMSCHAU, 2015, 62 (02): : M92 - M100
  • [46] Non-alcoholic fatty liver disease in 2016
    Townsend, S. A.
    Newsome, Philip N.
    BRITISH MEDICAL BULLETIN, 2016, 119 (01) : 143 - 156
  • [47] Non-Alcoholic Fatty Liver Disease in Cuba
    Castellanos-Fernandez, Marlen, I
    Crespo-Ramirez, Eduardo
    del Valle-Diaz, Sergio
    Barreto-Suarez, Eduardo
    Diaz-Elias, Javier O.
    Santalo-Rodriguez, Lorenzo
    Corrales-Alonso, Sahili
    Morales-Martinez, Ignacio
    Cedeno-Ramirez, Elisa
    Perez-Gonzalez, Teresita
    Gonzalez-Suero, Sila M.
    Ruenes-Domech, Caridad
    Infante-Velazquez, Mirtha
    Borges-Gonzalez, Susana A.
    Elvirez-Gutierrez, Angela
    Lazo-del Vallin, Sacha
    Villa-Jimenez, Oscar M.
    Labrada-Moreno, Liana M.
    MEDICC REVIEW, 2021, 23 (01) : 64 - 71
  • [48] Non-alcoholic fatty liver disease in pregnancy
    Benson, Charlotte S.
    Cobbold, Jeremy F.
    Frise, Charlotte J.
    OBSTETRIC MEDICINE, 2023, 16 (02) : 116 - 119
  • [49] Non-alcoholic fatty liver disease and lipotoxicity
    Wasilewska, Natalia
    Lebensztejn, Dariusz Marek
    CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2021, 7 (01) : 1 - 6
  • [50] Progressive Liver Fibrosis in Non-Alcoholic Fatty Liver Disease
    Ramai, Daryl
    Facciorusso, Antonio
    Vigandt, Erika
    Schaf, Bryan
    Saadedeen, Waleed
    Chauhan, Aditya
    di Nunzio, Sara
    Shah, Aashni
    Giacomelli, Luca
    Sacco, Rodolfo
    CELLS, 2021, 10 (12)